CG ONCOLOGY, INC. (CGON)
Mulay James 🟡 adjusted position in 2.0K shares (2 derivative) of CG Oncology, Inc. (CGON) at $60.12 Transaction Date: Jun 15, 2026 | Filing ID: 000002
Mulay James 🟡 adjusted position in 2.0K shares (2 derivative) of CG Oncology, Inc. (CGON) at $60.12 Transaction Date: Jun 15, 2026 | Filing ID: 000002
🔍 Mulay James (Executive)
Company: CG Oncology, Inc. (CGON)
Report Date: 2026-06-15
Transaction Summary:
Detailed Transactions and Holdings:
Date: 2026-06-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 654.00 | transaction_form_type: 4
Date: 2026-06-15 | Code: S | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1
Date: 2026-06-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,310.00 | transaction_form_type: 4
Date: 2026-06-15 | Code: S | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1
Date: 2026-06-15 | Code: M | Expires: 2033-06-13 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2
Date: 2026-06-15 | Code: M | Expires: 2033-12-12 | equity_swap_involved: 0 | shares_owned_after: 2,620.00 | transaction_form_type: 4 | Footnotes: F3
Footnotes: